Adarza BioSystems, Inc. is an early-stage medical diagnostics company developing a rapid and label-free biological assay platform for measuring clinical and point-of-care (POC) samples. In addition to performing sophisticated clinical tests within minutes, the technology is fully arrayable, potentially allowing hundreds of tests to be run simultaneously on a single chip. This proprietary platform technology will enable not only the next generation of clinical devices, but will revolutionize the medical diagnostics field.
Ultimately, we envision this technology driving a broad range of devices from future in-home diagnostics where the patient will self-diagnose illness with minimal physician input, to large-scale customizable research grade instrumentation. Adarza’s proprietary chip-based platform, Arrayed Imaging Reflectometry (AIR), achieves high sensitivity by detecting intensity changes in images of antireflective chips functionalized with highly specific detection molecules (proteins, DNA, etc.).